Shares of The Beauty Health Company (NASDAQ:SKIN) tumbled over 60% intra-day today following its significant miss on third-quarter estimates.
The company announced a Q3 loss of $0.56 per share, substantially below the analyst prediction of a $0.07 per share profit. Additionally, its revenue for the quarter was $97.4 million, falling short of the expected $116.23 million.
SKIN, the parent company of the Hydrafacial brand, adjusted its fiscal year 2023 sales forecast to between $385 and $400 million. It also revised its fiscal year adjusted EBITDA margin guidance to 5% to 6% and decided to suspend its long-term financial projections for 2025.
In a separate announcement, the company revealed that Andrew Stanleick will step down as president and CEO effective November 19. Marla Beck, a current director at BeautyHealth, will serve as interim CEO while the company searches for a permanent replacement.
At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com